Study of RO7515629 in Participants With HLA-G Positive Solid Tumors

Clinical trial NCT05769959 · TERMINATED

Trial details

NCT number: NCT05769959
Sponsor: Hoffmann-La Roche
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Cell Carcinoma Non-small Cell Lung Cancer Pancreatic Adenocarcinoma Colorectal Cancer Ovarian Neoplasms

Start date: 2023-06-15
Primary completion: 2024-03-19
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.